hydrocortisone acetate 20 MG/ML / lidocaine hydrochloride 20 MG/ML Rectal Cream
- RxCUI
- 1012233
- RxNorm name
- hydrocortisone acetate 20 MG/ML / lidocaine hydrochloride 20 MG/ML Rectal Cream
- Display name
- Hydrocortisone/Lidocaine (Rectal)
- Full name
- hydrocortisone acetate 20 MG/ML / lidocaine hydrochloride 20 MG/ML Rectal Cream
- Term type
- SCD
- Status
- Active
- Strength
- 2-2%
- Dose form
- Cream
- Route
- Rectal
- Updated
- 2026-06-16 07:06:31
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 102010
- Active start
- 102010
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
Derived Ingredient Concepts#
FDA NDC Products And Packages#
Package NDC, Product NDC, Name table| Package NDC | Product NDC | Name | Labeler | Application |
|---|
| 59088-816-01 | 59088-816 | Lidocaine HCl - Hydrocortisone Acetate Lidocaine HCl and Hydrocortisone Acetate | PureTek Corporation | |
RxNav Current And Historical NDCs#
NDC11, Source, Active table| NDC11 | Source | Active |
|---|
| 59088081601 | rxnav_ndcs | yes |
| 59088081624 | rxnav_ndcs | yes |
| 00482480107 | rxnav_historical_indirect | |
| 00482480124 | rxnav_historical_indirect | |
| 00482480907 | rxnav_historical_indirect | |
| 10337071697 | rxnav_historical_indirect | |
| 10337071698 | rxnav_historical_indirect | |
| 10337071699 | rxnav_historical_indirect | |
| 18754048307 | rxnav_historical | |
| 42192010207 | rxnav_historical_indirect | |
| 42192010224 | rxnav_historical_indirect | |
| 42192080224 | rxnav_historical | |
| 65179048307 | rxnav_historical | |
| 65179080107 | rxnav_historical_indirect | |
| 65179080907 | rxnav_historical_indirect | |
| 65255015304 | rxnav_historical | |
| 68032025701 | rxnav_historical | |
| 68032025724 | rxnav_historical | |
DailyMed RxNorm Mappings#
Set ID, RxNorm string, TTY table| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|
| ac6c6117-97cc-4b7a-a831-03fb23a54b70 | hydrocortisone acetate 20 MG/ML / lidocaine hydrochloride 20 MG/ML Rectal Cream | SCD | 3 | 59088-816 Lidocaine HCl 2%- Hydrocortisone Acetate 2% | 20250109 |
| ac6c6117-97cc-4b7a-a831-03fb23a54b70 | hydrocortisone acetate 2 % / lidocaine hydrochloride 2 % Rectal Cream | SY | 3 | 59088-816 Lidocaine HCl 2%- Hydrocortisone Acetate 2% | 20250109 |
| ac6c6117-97cc-4b7a-a831-03fb23a54b70 | hydrocortisone acetate 2 % / lidocaine HCl 2 % Rectal Cream | PSN | 3 | 59088-816 Lidocaine HCl 2%- Hydrocortisone Acetate 2% | 20250109 |
DailyMed Labels#
Set ID, Title, Manufacturer table| Set ID | Title | Manufacturer | Effective |
|---|
| ac6c6117-97cc-4b7a-a831-03fb23a54b70 | 59088-816 Lidocaine HCl 2%- Hydrocortisone Acetate 2% | PureTek Corporation | 20250109 |
Drug Classes#
Source, Class ID, Class table| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|
| ATC | N01BB | Amides | ATC1-4 | | lidocaine |
| ATC | S02DA | Analgesics and anesthetics | ATC1-4 | | lidocaine |
| ATC | D04AB | Anesthetics for topical use | ATC1-4 | | lidocaine |
| ATC | R02AD | Anesthetics, local | ATC1-4 | | lidocaine |
| ATC | C01BB | Antiarrhythmics, class Ib | ATC1-4 | | lidocaine |
| ATC | S02BA | Corticosteroids | ATC1-4 | | hydrocortisone |
| ATC | C05AA | Corticosteroids | ATC1-4 | | hydrocortisone |
| ATC | A07EA | Corticosteroids acting locally | ATC1-4 | | hydrocortisone |
| ATC | A01AC | Corticosteroids for local oral treatment | ATC1-4 | | hydrocortisone |
| ATC | S01BA | Corticosteroids, plain | ATC1-4 | | hydrocortisone |
| ATC | D07AA | Corticosteroids, weak (group I) | ATC1-4 | | hydrocortisone |
| ATC | D07XA | Corticosteroids, weak, other combinations | ATC1-4 | | hydrocortisone |
| ATC | S01CB | Corticosteroids/antiinfectives/mydriatics in combination | ATC1-4 | | hydrocortisone |
| ATC | H02AB | Glucocorticoids | ATC1-4 | | hydrocortisone |
| ATC | S01HA | Local anesthetics | ATC1-4 | | lidocaine |
| ATC | C05AD | Local anesthetics | ATC1-4 | | lidocaine |
| FDASPL | N0000175682 | Amide Local Anesthetic | EPC | has_epc | lidocaine |
| FDASPL | N0000175426 | Antiarrhythmic | EPC | has_epc | lidocaine |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | hydrocortisone |
| FDASPL | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine |
| MEDRT | D006854 | Hydrocortisone | CHEM | has_ingredient | hydrocortisone |
| MEDRT | D006854 | Hydrocortisone | CHEM | has_ingredient | hydrocortisone acetate |
| MEDRT | D008012 | Lidocaine | CHEM | has_ingredient | lidocaine hydrochloride |
| MEDRT | D008012 | Lidocaine | CHEM | has_ingredient | lidocaine |
| MEDRT | D000219 | Adams-Stokes Syndrome | DISEASE | ci_with | lidocaine |
| MEDRT | D000219 | Adams-Stokes Syndrome | DISEASE | ci_with | lidocaine hydrochloride |
| MEDRT | D000312 | Adrenal Hyperplasia, Congenital | DISEASE | may_treat | hydrocortisone |
| MEDRT | D000312 | Adrenal Hyperplasia, Congenital | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | hydrocortisone |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D002056 | Burns | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D002056 | Burns | DISEASE | may_treat | lidocaine |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | hydrocortisone |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D003877 | Dermatitis, Contact | DISEASE | may_treat | hydrocortisone |
| MEDRT | D003877 | Dermatitis, Contact | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D003881 | Dermatomycoses | DISEASE | ci_with | hydrocortisone |
| MEDRT | D003881 | Dermatomycoses | DISEASE | ci_with | hydrocortisone acetate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | lidocaine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | hydrocortisone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | hydrocortisone acetate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | lidocaine |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | lidocaine |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D004935 | Esophageal Diseases | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D004935 | Esophageal Diseases | DISEASE | may_treat | lidocaine |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | hydrocortisone |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | lidocaine hydrochloride |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | lidocaine |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | hydrocortisone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D009059 | Mouth Diseases | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D009059 | Mouth Diseases | DISEASE | may_treat | lidocaine |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | lidocaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | lidocaine |
| MEDRT | D010146 | Pain | DISEASE | may_treat | lidocaine |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | hydrocortisone |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | hydrocortisone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D012769 | Shock | DISEASE | may_treat | hydrocortisone |
| MEDRT | D012769 | Shock | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D012876 | Skin Diseases, Parasitic | DISEASE | ci_with | hydrocortisone |
| MEDRT | D012876 | Skin Diseases, Parasitic | DISEASE | ci_with | hydrocortisone acetate |
| MEDRT | D017193 | Skin Diseases, Viral | DISEASE | ci_with | hydrocortisone |
| MEDRT | D017193 | Skin Diseases, Viral | DISEASE | ci_with | hydrocortisone acetate |
| MEDRT | D013224 | Status Asthmaticus | DISEASE | may_treat | hydrocortisone |
| MEDRT | D013224 | Status Asthmaticus | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D013614 | Tachycardia, Paroxysmal | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D013614 | Tachycardia, Paroxysmal | DISEASE | may_treat | lidocaine |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | lidocaine |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D014382 | Tuberculosis, Cutaneous | DISEASE | ci_with | hydrocortisone |
| MEDRT | D014382 | Tuberculosis, Cutaneous | DISEASE | ci_with | hydrocortisone acetate |
| MEDRT | D018754 | Ventricular Dysfunction | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | lidocaine |
| MEDRT | D018879 | Ventricular Premature Complexes | DISEASE | may_treat | lidocaine |
| MEDRT | D018879 | Ventricular Premature Complexes | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | hydrocortisone acetate |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | hydrocortisone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | hydrocortisone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | hydrocortisone acetate |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | lidocaine hydrochloride |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | lidocaine |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | hydrocortisone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008330 | Cardiac Rhythm Alteration | PE | has_pe | lidocaine hydrochloride |
| MEDRT | N0000008330 | Cardiac Rhythm Alteration | PE | has_pe | lidocaine |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | hydrocortisone |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008472 | Decreased Cardiac Muscle Organized Electrical Activity | PE | has_pe | lidocaine hydrochloride |
| MEDRT | N0000008472 | Decreased Cardiac Muscle Organized Electrical Activity | PE | has_pe | lidocaine |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | hydrocortisone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | hydrocortisone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | hydrocortisone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | hydrocortisone |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | hydrocortisone |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | hydrocortisone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | hydrocortisone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | hydrocortisone acetate |
Properties#
Category, Property, Value table| Category | Property | Value |
|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 20 MG/ML (expressed as hydrocortisone acetate) / 20 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| ATTRIBUTES | TTY | SCD |
| CODES | MMSL_CODE | BD19799 |
| CODES | RxCUI | 1012233 |
| CODES | SPL_SET_ID | ac6c6117-97cc-4b7a-a831-03fb23a54b70 |
| CODES | VUID | 4026268 |
| NAMES | Prescribable Synonym | hydrocortisone acetate 2 % / lidocaine HCl 2 % Rectal Cream |
| NAMES | RXNAV_STR | hydrocortisone acetate 20 MG/ML / lidocaine hydrochloride 20 MG/ML Rectal Cream |
| NAMES | RxNorm Name | hydrocortisone acetate 20 MG/ML / lidocaine hydrochloride 20 MG/ML Rectal Cream |
| NAMES | RxNorm Synonym | hydrocortisone acetate 2 % / lidocaine hydrochloride 2 % Rectal Cream |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |